Cruz-Merino, L. d. l., Gion, M., Cruz-Jurado, J., Quiroga, V., Andrés, R., Moreno, F., . . . Rojo, F. (2021). Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. MDPI AG.
Cita Chicago Style (17a ed.)Cruz-Merino, Luis de la, et al. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. MDPI AG, 2021.
Cita MLA (8a ed.)Cruz-Merino, Luis de la, et al. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.